Is rituximab a potential new therapy in systemic sclerosis? new evidence indicates the presence of CD20-positive B-lymphocytes in scleroderma skin

J Clin Rheumatol. 2004 Jun;10(3):155. doi: 10.1097/01.rhu.0000129090.86550.1e.
No abstract available

Publication types

  • Letter